Why Are CPG Brands Freaking Out About Ozempic?
This week SuperGut CEO Marc Washington joins the podcast to talk about why new GLP-1 drugs like Ozempic and Wegovy are keeping CPG brand CEOs up at night.
These new drugs, which got their start as a new class of pharmaceuticals that help contol type 2 diabetes, have become very popular in recent years as weight loss drug. They are hugely effective in suppressing appetites and reducing the overall calorie intake of those taking them, so much so that some speculate that they could have a significant impact on overall demand for food if, as predicted, tens of millions begin to take them in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.